Brochure

Capsugel®️ Zephyr™️ Dry-Powder Inhalation Capsule Portfolio

Capsugel®️ Zephyr™️ Dry-Powder Inhalation Capsule Portfolio

Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery. Delivering a uniform dose in a portable, easy-to-use system, capsule-based DPI devices are a simple and cost-effective way to deliver inhalable medication. Capsugel® Zephyr™ is Lonza’s customizable dry-powder inhalation capsule portfolio that is optimized to provide superior performance and compatibility between the capsule/device and capsule/formulation.